Ваксигриптетра

Ваксигриптетра is a quadrivalent influenza vaccine designed to protect against four flu virus strains, including B/Phuket/3073/2013-like and B/Michigan/01/2021. This seasonal vaccine helps reduce flu-related illness and complications. Suitable for adults and children, it is administered annually to match circulating flu strains.

Ваксигриптетра is used to provide active immunization against influenza caused by specific virus strains. It helps prevent flu-related symptoms and complications in individuals aged 6 months and older. The vaccine is updated annually to match the most prevalent flu strains, offering broad protection. It is particularly recommended for high-risk groups such as the elderly, pregnant women, and those with chronic health conditions.

After vaccination, the immune system recognizes the inactivated flu virus components in Ваксигриптетра and produces antibodies. These antibodies help protect the body from infection if exposed to the actual flu virus. Common effects include mild soreness at the injection site and mild flu-like symptoms, which typically resolve quickly.

Ваксигриптетра should be stored refrigerated between 2°C and 8°C and protected from light. It is for intramuscular or subcutaneous use only and should not be administered intravascularly. Individuals with a known allergy to eggs or any vaccine component should consult a healthcare provider before vaccination. Always inform your healthcare professional about any current medications or medical conditions.

Ваксигриптетра may interact with immunosuppressive therapies, reducing its effectiveness. Concurrent use with other vaccines should be spaced at least one week apart unless medically advised. No significant interactions with common medications like pain relievers or antihistamines have been reported, but always disclose your full medication list to your healthcare provider.